Howard W. Donnelly joined the AngioDynamics Board of Directors in March 2004 and is the President of Concert Medical LLC, a manufacturer of interventional medical devices. In addition, Mr. Donnelly is President and Chief Executive Officer of HydroCision Inc., a medical device manufacturer focused on the spine market. From 1999 to 2002, he was President of Level 1 Inc., a medical device manufacturer and a subsidiary of Smiths Group. From 1990-99, Mr. Donnelly was employed at Pfizer Inc., with his last position being Vice President, Business Planning and Development, for Pfizer's Medical Technology Group from 1997-99.
President and Chief Executive Officer James Clemmer joined AngioDynamics in April 2016, bringing more than 25 years of leadership within the healthcare industry and a proven track record of success.
Prior to AngioDynamics, Clemmer served as president of the $1.8 billion medical supplies segment at Covidien plc., where he directed strategic and day-to-day operations for global business divisions that collectively manufactured 23 different product categories. In addition, he managed global manufacturing, research and development, operational excellence, business development and all other functions associated with the medical supplies business. Prior to his role at Covidien, Clemmer served as group president at Kendall Healthcare, where he managed the US business across five divisions and built the strategic plan for the Medical Supplies segment before it was spun off from Tyco. Clemmer began his career at Sage Products, Inc.
Clemmer currently serves on the Board of Directors for AngioDynamics and Lantheus Medical Imaging. Clemmer is a graduate of the Massachusetts College of Liberal Arts.
Eileen Auen most recently served as Executive Chairman of Helios, a $1 billion healthcare services firm formed by the merger of PMSI and Progressive Medical in 2013. Prior roles include Chairman and Chief Executive Officer of PMSI, Head of Healthcare Management at Aetna, and Chief Executive Officer of APS Healthcare. She currently provides consulting services to the healthcare industry through Deep Run Consulting, a firm she founded. Ms. Auen earned a bachelor’s degree in Economics and Finance from Towson University, and an M.B.A. from the University of Virginia School of Business. Ms. Auen currently serves as the Lead Director for ICF International (NASDAQ:ICFI). She also serves as a member of the Board of Directors for Medstar Union Memorial Hospital and Tufts Health Plan.
Jeffrey G. Gold has served as Director since 1997. Mr. Gold is a Venture Partner for Longitude Capital, a healthcare venture capital fund. Mr. Gold was President and Chief Executive Officer of CryoVascular Systems, a peripheral vascular disease device company, from 2001 through its sale to Boston Scientific in 2005. From 1997 to 2001 he was Executive Vice President and Chief Operating Officer of CardioThoracic Systems Inc., a company engaged in the development and introduction of devices for beating-heart coronary bypass surgery. Before that, Mr. Gold spent 18 years with Cordis Corporation in a variety of senior management roles, including Vice President of Manufacturing and Vice President of Research and Development, and was a co-founder and President of Cordis Endovascular Systems, a Cordis subsidiary engaged in the interventional neuroradiology business. At Cordis, Mr. Gold also had responsibility for the peripheral vascular business. He serves on the board of directors of several start-up medical device companies and is a member of the Executive Committee for the Center for Entrepreneurship and Innovation at the University of Florida, as well as the Commercialization Advisory Board for the Cleveland Clinic.
Kevin Gould, former Chief Operating Officer of Tyco Healthcare, joined AngioDynamics' Board of Directors in October 2010. Mr. Gould has more than 30 years of healthcare industry experience. From 1991 until 2009, he held various management positions at Tyco Healthcare, now known as Covidien after going public in 2007. Prior to serving as the company's COO, he was President of North America operations of Tyco Healthcare. Mr. Gould has served on the Board of Trustees of St. Elizabeth's Hospital in Brighton, Massachusetts. He earned his M.B.A. from Anna Maria College in Paxton, Mass., and his B.A. from St. Anselm's College in Manchester, N. H.
Wesley E. Johnson Jr. joined the Company's Board of Director's in January 2007. From 2003-07, Mr. Johnson served as a member of the board of RITA Medical Systems Inc. Since February 2008, Mr. Johnson has served as President, Chief Executive Officer and director of Cardiokinetix Inc., a developer of medical devices for the treatment of congestive heart failure. From October 2005 to February 2008 he served as General Manager of Abbott Spine S.A., a division of Abbott Laboratories. From June 2003 to October 2005, Mr. Johnson served as Division Vice President, Finance for Abbott Spine. From May 1999 to June 2003 he served as Vice President of Operations and Chief Financial Officer for Spinal Concepts. Mr. Johnson has a B.B.A. in accounting from Texas A&M University and became a Certified Public Accountant in 1981.
Steve LaPorte joined the AngioDynamics Board of Directors in January 2007. From 2005-07, Mr. LaPorte served as a member of the RITA Medical Systems Inc. Board of Directors. Mr. LaPorte is a Venture Partner for Onset Ventures, serves as the Chief Technology Officer for Intelect Medical, and serves on the boards of Valeritas and Biocontrol. From 2002 until his retirement in August 2005, Mr. LaPorte served as Vice President of Neuro Ventures and Business Development at Medtronic Inc., a global leader in medical technology. From 2000-02, Mr. LaPorte served as Vice President and General Manager of Medtronic's Drug Delivery Division; from 1994 to 2000, he held the position of Vice President and General Manager of Medtronic's Electrophysiology Systems Division; and from 1988-94 he was the Vice President of Operations for Medtronic's Neurological Division. He began his career at Medtronic in 1978. Mr. LaPorte received his M.B.A. from the University of Minnesota and a B.S. in mathematics and computer science from the University of Wisconsin-Stevens Point.
Dennis S. Meteny joined the AngioDynamics Board of Directors in March 2004. Mr. Meteny is President and Chief Executive Officer of Cygnus Manufacturing Company LLC, a privately held manufacturer of minimally- and non-invasive medical device products; health and safety components; and high-precision transportation, aerospace and industrial products. From 2003-06, Mr. Meteny was an Executive-in-Residence at the Pittsburgh Life Sciences Greenhouse, a strategic economic development initiative of the University of Pittsburgh Health System, Carnegie Mellon University, the University of Pittsburgh, the state of Pennsylvania and local foundations. From 2001-03 he was President and Chief Operating Officer of TissueInformatics Inc., a privately-held company engaged in the medical imaging business. From 2000-01, Mr. Meteny was a business consultant to various technology companies. Prior to that, Mr. Meteny spent 15 years in several executive-level positions, including as President and Chief Executive Officer from 1994-99, of Respironics Inc., a cardio-pulmonary medical device company. Mr. Meteny holds a B.S. in accounting from The Pennsylvania State University and an M.B.A. from the University of Pittsburgh.
Jan Reed was most recently Senior Vice President, General Counsel and Corporate Secretary at Walgreens Boots Alliance, Inc., a global pharmacy-led, health and wellbeing enterprise with annual revenues in excess of $115 billion. Prior to this role, Ms. Reed also served as Executive Vice President of Human Resources, General Counsel and Corporate Secretary of Solo Cup Company, and Associate General Counsel, Corporate Secretary and Chief Governance Officer at Baxter International Inc. Ms. Reed earned a Bachelor of Arts degree, with honors, in Psychology from the University of Michigan, and a Juris Doctor from Northwestern University School of Law. Ms. Reed currently serves as a member of the Board of Directors for Stepan Company (NYSE:SCL).